Temporal expression of HIV-1 envelope proteins in baculovirus-infected insect cells: implications for glycosylation and CD4 binding.
Three different human immunodeficiency virus type I (HIV-1) envelope derived recombinant proteins and the full length human CD4 polypeptide were expressed in Spodoptera frugiperda (Sf9) cells. DNA constructs encoding CD4, gp120, gp160, and gp160 delta (full length gp160 minus the transmembrane and cytoplasmic region of gp41) were cloned into the baculovirus expression vector pVL941 or a derivative and used to generate recombinant viruses in a cotransfection with DNA from Autographa californica nuclear polyhedrosis virus (AcMNPV). Western blotting of cell extracts of the recombinant HIV-1 proteins showed that for each construct two major bands specifically reacted with anti-HIV-1 envelope antiserum. These bands corresponded to glycosylated and nonglycosylated versions of the HIV proteins as determined by 3H-mannose labeling and tunicamycin treatment of infected cells. A time course of HIV envelope expression revealed that at early times post-infection (24 hours) the proteins were fully glycosylated and soluble in nonionic detergents. However, at later times postinfection (48 hours), expression levels of recombinant protein reached a maximum but most of the increase was due to a rise in the level of the nonglycosylated species, which was largely insoluble in nonionic detergents. Thus, it appears that Sf9 cells cannot process large amounts of glycosylated recombinant proteins efficiently. As a measure of biological activity, the CD4 binding ability of both glycosylated and nonglycosylated recombinant HIV envelope proteins was tested in a coimmunoprecipitation assay. The results showed that CD4 and the glycosylated versions of recombinant gp120 or gp160 delta specifically associated with one another in this analysis. Nonglycosylated gp120 or gp160 delta proteins from tunicamycin-treated cultures did immunoprecipitate with anti-HIV-1 antiserum but did not interact with CD4. We conclude that production of native HIV envelope proteins, as measured by addition of carbohydrate side chains and ability to bind CD4, peaks early after infection in baculovirus-infected insect cells.
Murphy
C I
CI
Cambridge Bioscience Corporation, Worcester, MA 01605.
Lennick
M
M
Lehar
S M
SM
Beltz
G A
GA
Young
E
E
D000818:Animals; D016367:Baculoviridae / Q000187:drug effects / Q000235:genetics*; D001483:Base Sequence; D015153:Blotting, Western; D015704:CD4 Antigens / Q000235:genetics*; D015870:Gene Expression; D015686:Gene Products, env / Q000235:genetics*; D006031:Glycosylation; D015699:HIV Envelope Protein gp120 / Q000235:genetics*; D019302:HIV Envelope Protein gp160; D015497:HIV-1 / Q000235:genetics*; D007700:Kinetics; D008358:Mannose / Q000378:metabolism; D008969:Molecular Sequence Data; D009036:Moths / Q000187:drug effects / Q000382:microbiology*; D011498:Protein Precursors / Q000235:genetics*; D011948:Receptors, Antigen, T-Cell / Q000235:genetics / Q000378:metabolism*; D012995:Solubility; D014162:Transfection; D014316:Tritium; D014415:Tunicamycin / Q000494:pharmacology
D015704:CD4 Antigens; D015686:Gene Products, env; D015699:HIV Envelope Protein gp120; D019302:HIV Envelope Protein gp160; D011498:Protein Precursors; D011948:Receptors, Antigen, T-Cell; D014316:Tritium; D014415:Tunicamycin; D008358:Mannose